| 000 | 01278 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516202256.0 | ||
| 264 | 0 | _c20141124 | |
| 008 | 201411s 0 0 eng d | ||
| 022 | _a2213-8595 | ||
| 024 | 7 |
_a10.1016/S2213-8587(13)70036-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLaurent, Stéphane | |
| 245 | 0 | 0 |
_aDaglutril for treatment of renal damage in hypertensive patients with type 2 diabetes: disappointment or hope? _h[electronic resource] |
| 260 |
_bThe lancet. Diabetes & endocrinology _cSep 2013 |
||
| 300 |
_a2-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 |
_aAlbuminuria _xdrug therapy |
| 650 | 0 | 4 |
_aAspartic Acid Endopeptidases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aBenzazepines _xtherapeutic use |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aEndothelin-Converting Enzymes |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetalloendopeptidases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNeprilysin _xantagonists & inhibitors |
| 773 | 0 |
_tThe lancet. Diabetes & endocrinology _gvol. 1 _gno. 1 _gp. 2-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S2213-8587(13)70036-6 _zAvailable from publisher's website |
| 999 |
_c23633601 _d23633601 |
||